Character Biosciences, Inc. — Form D
Character Biosciences, Inc. of JERSEY CITY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-12. The offering totals $110.5M, of which $48.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-05-12
- Form: D
- Accession: 0002066192-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $110.5M
- Amount sold: $48.2M
- Remaining: $62.3M
- Investors: 16
- Date of first sale: 2025-03-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-545759
Issuer
- Name: Character Biosciences, Inc.
- CIK: 0002066192
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3 2nd Street, Suite 302, JERSEY CITY, NJ, 07311-4056
- Phone: (929) 310-5933
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jason Hafler | Director | South San Francisco, CA |
| Vivek Garipalli | Director | Nashville, TN |
| Reut Shema | Director | Ra'anana, L3 |
| Mayssa Attar | Director | Jersey City, NJ |
| James Kasuboski | Director | Jersey City, NJ |
| Cheng Zhang | Director | Jersey City, NJ |
| Cheng Zhang | Executive Officer | Jersey City, NJ |
| Peter DiLaura | Director | Jersey City, NJ |
| Nick Olsen | Director | Watertown, MA |
Other filings by this issuer (1)
More